CN104819966A - 杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 - Google Patents
杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 Download PDFInfo
- Publication number
- CN104819966A CN104819966A CN201510132677.5A CN201510132677A CN104819966A CN 104819966 A CN104819966 A CN 104819966A CN 201510132677 A CN201510132677 A CN 201510132677A CN 104819966 A CN104819966 A CN 104819966A
- Authority
- CN
- China
- Prior art keywords
- cell
- probe
- fluorescence
- imaging
- dyeing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 239000007850 fluorescent dye Substances 0.000 title abstract description 9
- 238000012632 fluorescent imaging Methods 0.000 title abstract 3
- 239000000523 sample Substances 0.000 claims abstract description 173
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 10
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims abstract description 6
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 5
- 201000011510 cancer Diseases 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 226
- 239000000243 solution Substances 0.000 claims description 62
- 235000015097 nutrients Nutrition 0.000 claims description 44
- 238000003384 imaging method Methods 0.000 claims description 43
- 238000004043 dyeing Methods 0.000 claims description 38
- 239000001963 growth medium Substances 0.000 claims description 37
- 238000000799 fluorescence microscopy Methods 0.000 claims description 24
- 238000002073 fluorescence micrograph Methods 0.000 claims description 20
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 18
- 239000012980 RPMI-1640 medium Substances 0.000 claims description 16
- 230000003834 intracellular effect Effects 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 238000009826 distribution Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000009977 dual effect Effects 0.000 claims description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 241000534944 Thia Species 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 210000001082 somatic cell Anatomy 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 235000004458 antinutrient Nutrition 0.000 claims description 4
- 231100000433 cytotoxic Toxicity 0.000 claims description 4
- 230000001472 cytotoxic effect Effects 0.000 claims description 4
- 230000005284 excitation Effects 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 230000006907 apoptotic process Effects 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 abstract description 8
- 239000000975 dye Substances 0.000 abstract description 7
- 230000035699 permeability Effects 0.000 abstract description 3
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 239000011701 zinc Substances 0.000 description 47
- 230000012447 hatching Effects 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 11
- 238000011160 research Methods 0.000 description 9
- 230000001988 toxicity Effects 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 6
- 238000001000 micrograph Methods 0.000 description 6
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 150000001492 aromatic hydrocarbon derivatives Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 150000001455 metallic ions Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- -1 oxacalixarenes Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- IGHBXJSNZCFXNK-UHFFFAOYSA-N 4-chloro-7-nitrobenzofurazan Chemical compound [O-][N+](=O)C1=CC=C(Cl)C2=NON=C12 IGHBXJSNZCFXNK-UHFFFAOYSA-N 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- FRTNIYVUDIHXPG-UHFFFAOYSA-N acetic acid;ethane-1,2-diamine Chemical class CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN FRTNIYVUDIHXPG-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000004715 cellular signal transduction Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003920 environmental process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000002504 synaptic vesicle Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510132677.5A CN104819966B (zh) | 2015-03-25 | 2015-03-25 | 杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510132677.5A CN104819966B (zh) | 2015-03-25 | 2015-03-25 | 杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104819966A true CN104819966A (zh) | 2015-08-05 |
CN104819966B CN104819966B (zh) | 2018-09-11 |
Family
ID=53730322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510132677.5A Active CN104819966B (zh) | 2015-03-25 | 2015-03-25 | 杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104819966B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105039242A (zh) * | 2015-08-26 | 2015-11-11 | 中国科学院生态环境研究中心 | 一种促进Ru(II)金属络合物细胞核摄取的方法 |
CN107219209A (zh) * | 2017-07-21 | 2017-09-29 | 贵州大学 | 一种双通道荧光成像检测活细胞中微量Al3+的方法 |
CN108586502A (zh) * | 2018-03-15 | 2018-09-28 | 中国科学院苏州生物医学工程技术研究所 | 双杯[4]芳烃衍生物的金属配合物及其合成方法和应用 |
CN111057034A (zh) * | 2019-12-02 | 2020-04-24 | 西北师范大学 | 香豆素功能化的柱[5]芳烃及其合成和应用 |
CN113831911A (zh) * | 2021-08-19 | 2021-12-24 | 南开大学 | 一种基于细胞外囊泡的缺氧响应共组装体系及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103342699A (zh) * | 2013-07-16 | 2013-10-09 | 贵州大学 | 一种香豆素-硫杂杯[4]芳烃荧光试剂及其制备方法和应用 |
CN104101577A (zh) * | 2014-08-05 | 2014-10-15 | 贵州大学 | 一种比率吸收光度法测定Ag+或F-的方法 |
CN104122222A (zh) * | 2014-08-07 | 2014-10-29 | 贵州大学 | 一种检测微量Zn2+或F-的紫外比率吸收光谱分析法 |
CN104198449A (zh) * | 2014-08-08 | 2014-12-10 | 贵州大学 | 一种用于活细胞成像的荧光探针方法 |
-
2015
- 2015-03-25 CN CN201510132677.5A patent/CN104819966B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103342699A (zh) * | 2013-07-16 | 2013-10-09 | 贵州大学 | 一种香豆素-硫杂杯[4]芳烃荧光试剂及其制备方法和应用 |
CN104101577A (zh) * | 2014-08-05 | 2014-10-15 | 贵州大学 | 一种比率吸收光度法测定Ag+或F-的方法 |
CN104122222A (zh) * | 2014-08-07 | 2014-10-29 | 贵州大学 | 一种检测微量Zn2+或F-的紫外比率吸收光谱分析法 |
CN104198449A (zh) * | 2014-08-08 | 2014-12-10 | 贵州大学 | 一种用于活细胞成像的荧光探针方法 |
Non-Patent Citations (3)
Title |
---|
YU FU等: "Use of a new thiacalix[4]arene derivative bearing two 4-chloro-7-nitrobenzofurazan groups as a colorimetric and fluorescent chemosensor for Ag+ and AcO−", 《SENSORS AND ACTUATORS B 》 * |
王鹤文等: "键合香豆素席夫碱基的杯[4]芳烃的合成及其对金属离子的荧光识别作用", 《应用化学》 * |
赵江林等: "硫杂杯[4]-冠-5稠杂环类荧光探针的合成", 《全国第十五届大环化学暨第七届超分子化学学术讨论会摘要集》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105039242A (zh) * | 2015-08-26 | 2015-11-11 | 中国科学院生态环境研究中心 | 一种促进Ru(II)金属络合物细胞核摄取的方法 |
CN105039242B (zh) * | 2015-08-26 | 2018-08-31 | 中国科学院生态环境研究中心 | 一种促进Ru(II)金属络合物细胞核摄取的方法 |
CN107219209A (zh) * | 2017-07-21 | 2017-09-29 | 贵州大学 | 一种双通道荧光成像检测活细胞中微量Al3+的方法 |
CN108586502A (zh) * | 2018-03-15 | 2018-09-28 | 中国科学院苏州生物医学工程技术研究所 | 双杯[4]芳烃衍生物的金属配合物及其合成方法和应用 |
CN108586502B (zh) * | 2018-03-15 | 2019-12-27 | 中国科学院苏州生物医学工程技术研究所 | 双杯[4]芳烃衍生物的金属配合物及其合成方法和应用 |
CN111057034A (zh) * | 2019-12-02 | 2020-04-24 | 西北师范大学 | 香豆素功能化的柱[5]芳烃及其合成和应用 |
CN113831911A (zh) * | 2021-08-19 | 2021-12-24 | 南开大学 | 一种基于细胞外囊泡的缺氧响应共组装体系及其制备方法 |
CN113831911B (zh) * | 2021-08-19 | 2022-07-22 | 南开大学 | 一种基于细胞外囊泡的缺氧响应共组装体系及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104819966B (zh) | 2018-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104819966A (zh) | 杯芳烃荧光探针应用于活细胞中Zn2+、F-荧光成像的方法 | |
Trouillon et al. | Chemical analysis of single cells | |
CN104198449B (zh) | 一种用于活细胞成像的荧光探针方法 | |
O'Riordan et al. | Sensing intracellular oxygen using near-infrared phosphorescent probes and live-cell fluorescence imaging | |
CN110982513B (zh) | 一种荧光碳点的制备方法及其在细胞成像中的应用 | |
US10351707B2 (en) | Water-soluble iron ion fluorescent probe and preparation method thereof | |
Wang et al. | Imaging of cellular oxygen via two-photon excitation of fluorescent sensor nanoparticles | |
CN108117544A (zh) | 一种可逆二氧化硫/亚硫酸(氢)盐的荧光探针 | |
JP6817610B2 (ja) | 三次元培養表皮モデル及びその製造方法、ならびに三次元培養表皮モデルの使用方法 | |
CN107601455A (zh) | 长时间靶向成像活细胞内rna荧光碳点的制备方法及其产品和应用 | |
CN105017196A (zh) | 一种检测肼的近红外比率荧光探针及其应用 | |
CN107325814A (zh) | 一种荧光硅纳米点及其制备方法与应用 | |
CN110243794A (zh) | 一种基于石墨烯量子点的检测二氧化硫的荧光探针及其应用 | |
CN104792756A (zh) | 四-对-磺酸基-苯基卟啉衍生物作为荧光探针在检测锌离子方面的应用 | |
CN112500386A (zh) | 基于吡啰红肟的近红外HClO荧光探针、制备及其应用 | |
CN113698379B (zh) | 一种用于检测多硫化氢的荧光探针及其制备方法和应用 | |
CN104962279B (zh) | 一种no3‑离子的检测试剂及应用 | |
CN105548097B (zh) | 一种利用荧光探针在极端pH值下的活性细胞成像方法 | |
CN104498579B (zh) | 一种用于癌细胞中Zn2+监测的荧光探针方法 | |
CN111286323B (zh) | 一种自靶向细胞核的荧光碳点及其制备方法和应用 | |
CN111072011B (zh) | 一种线粒体-核仁可逆迁移荧光碳点的制备及在监测细胞活性中的应用 | |
CN107290197A (zh) | 一种活细胞线粒体数量染色检测方法 | |
CN114057604A (zh) | 一种细胞核荧光染料及其染色方法 | |
CN104833664B (zh) | 一种活细胞中稀土离子La3+、Lu3+的荧光成像方法 | |
NL2032008B1 (en) | Fluorescent labeling kit for a tumor cell nucleus and labeling method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210909 Address after: Room 501, 5 / F, building 90, guangqumennei street, Dongcheng District, Beijing 100062 Patentee after: Hundred Foundation (Beijing) International Business Management Consulting Co.,Ltd. Address before: 550025 science and Technology Department, Guizhou University, Huaxi District, Guizhou, Guiyang Patentee before: Guizhou University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220117 Address after: 300304 room 1-2050, Block E, No. 6, Huafeng Road, Huaming high tech Industrial Zone, Dongli District, Tianjin Patentee after: Zhongzhi online Co.,Ltd. Address before: Room 501, 5 / F, building 90, guangqumennei street, Dongcheng District, Beijing 100062 Patentee before: Hundred Foundation (Beijing) International Business Management Consulting Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150805 Assignee: Tianjin Hezheng measurement and Testing Co.,Ltd. Assignor: Zhongzhi online Co.,Ltd. Contract record no.: X2023980040389 Denomination of invention: Application of Calixarene Fluorescence Probe in Fluorescence Imaging of Zn2+, F-in Living Cells Granted publication date: 20180911 License type: Common License Record date: 20230825 |
|
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150805 Assignee: Tianjin Xiehe Bojing Medical Diagnostic Technology Co.,Ltd. Assignor: Zhongzhi online Co.,Ltd. Contract record no.: X2024980004474 Denomination of invention: Application of calixarenes fluorescent probes in fluorescent imaging of Zn2+and F-in living cells Granted publication date: 20180911 License type: Common License Record date: 20240416 |